Immune response to the endothelium in myocarditis, dilated cardiomyopathy and rejection after heart transplantation

Area of Science:

• Cardiovascular Science
• Immunology
• Transplantation Biology

Background:

• The role of endothelial cells in inflammatory heart disease and heart transplant rejection is not fully understood.
• Investigating immune reactions against endothelial cells is critical for improving transplant outcomes.

Purpose of the Study:

• To determine if an immune reaction against endothelial cells occurs in patients with inflammatory heart disease and after heart transplantation.
• To assess the significance of endothelial cells as targets in heart transplant rejection.

Main Methods:

• Examination of endomyocardial biopsies from patients with myocarditis, dilated cardiomyopathy, and varying degrees of heart transplant rejection.
• Comparison with normal donor hearts using monoclonal endothelial-specific antibodies (EN4, Pal-E, F VIII-related antigen).

Main Results:

• Endothelial cells were consistently stained by the EN4 antibody.
• Significant increases in Pal-E and F VIII-related antigen binding were observed specifically in cases of moderate to severe transplant rejection.
• No significant changes in antibody binding were noted in myocarditis or dilated cardiomyopathy groups.

Conclusions:

• Endothelial cells are important targets in heart transplant rejection, beyond their role as antigen-presenting cells.
• Damage or cytolysis of endothelial cells during rejection can lead to increased transendothelial permeability.
• Functional decrease in antigen presentation by endothelial cells may contribute to transplant rejection mechanisms.